Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation-Reference-Cited by-同舟云学术

Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation

Published:1992-01 Issue:4 Volume:4 Page:355-368
ISSN:0955-2235
Container-title:Progress in Growth Factor Research
language:en
Short-container-title:Progress in Growth Factor Research

Author:

Trinchieri Giorgio,Wysocka Maria,D'Andrea Annalisa,Rengaraju Manthrasalam,Aste-Amezaga Miguel,Kubin Marek,Valiante Nicholas M.,Chehimi Jihed

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences,General Medicine

Reference43 articles.

1. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice;Bancroft;J Immunol.,1989

2. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSFIL-12): Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2;Chan;J Immunol.,1992

3. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers;Chan;J Exp Med.,1991

4. Natural killer cell stimulatory factor (NKSF) increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients;Chehimi;J Exp Med.,1992

5. Enhancing effect of natural killer cell stimulatory factor (NKSFIL-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells;Chehimi;Eur J Immunol.,1993

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy;Frontiers in Immunology;2024-06-04

2. Glycosylated SARs Cov 2 interaction with plant lectins;Glycoconjugate Journal;2024-05-15

3. Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy;Translational Medicine Communications;2024-05-14

4. Objective Response after Immune Checkpoint Inhibitors in a Chemotherapy-Refractory pMMR/MSS Metastatic Rectal Cancer Patient Primed with Experimental AlloStim® Immunotherapy.;2024-04-03

5. An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses;Med;2023-05